ReviewsAcute Pancreatitis in Chronic Dialysis PatientsBarbara, Mary MD*; Tsen, Adrianne DO*; Rosenkranz, Laura MD†Author Information From the *Department of Medicine, Division of Hospital and General Medicine, and †Department of Medicine, Division of Gastroenterology, UT Health San Antonio, San Antonio, TX. Received for publication February 4, 2018; accepted June 12, 2018. Address correspondence to: Mary Barbara, MD, 8638 Huebner Rd, Apt 3446, San Antonio, TX 78240 (e-mail: firstname.lastname@example.org). The authors declare no conflict of interest. Pancreas: September 2018 - Volume 47 - Issue 8 - p 946-951 doi: 10.1097/MPA.0000000000001119 Buy Metrics Abstract The annual incidence of acute pancreatitis (AP) ranges from 4.9 to 73.4 cases per 100,000 worldwide. Patients with end-stage renal disease on dialysis have an increased risk for developing AP compared with patients without renal disease. In addition to the general population risk factors, there are factors related to renal insufficiency and dialysis process that might predispose to AP in this population. Clinical features and diagnosis are the same as those in patients without renal failure; however, amylase and lipase levels should be interpreted cautiously as they might be falsely elevated in renal failure. In this article, we will describe the risk factors that are exclusive to this population. In addition, we will also focus on the laboratory indices and clinical features that are unique to this population with patients with end-stage renal disease. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.